Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis

Clicks: 1
ID: 313432
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #457 of 530 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 530 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Lenacapavir PrEP implementation across 17 U.S. sites (n=501) was characterized by delays in initiation driven by payer processes. Early non-persistence was uncommon (3.6%) but exceeded clinical trial discontinuation rates and was strongly associated with abdominal injections and injection-site reactions requiring clinical contact, underscoring modifiable clinical and structural barriers to early persistence.
Reference Key
openalex_W7161404577 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Aniruddha Hazra, Philip A. Chan, Meredith Clement, Christopher Kaperak, Hussein Safa, Joshua P Havens, Sandra A Springer, Jill Blumenthal, Matthew Spinelli, Susanne Doblecki-Lewis, Ami Multani, June Gipson, Joesph Cherabie, Rona Vail, Stephen Sukumaran, Chase A Cannon, R. Lillis, Isolde Butler, Christian Turner, Ellen Taraschi, Gilianne Narcisse-Cempini, Leah Kunzmann, Romini Smith, Drew Halbur, Rupa Patel
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2026
DOI
10.1093/cid/ciag316
URL
https://doi.org/10.1093/cid/ciag316
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.